Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2497PDF: 701HTML: 2281 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2160PDF: 1001HTML: 1971Characteristic of study group: 175 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1963PDF: 1576HTML: 344 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2393PDF: 755HTML: 1719 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1827PDF: 816HTML: 1229 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1414PDF: 497HTML: 237 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1881PDF: 1329HTML: 245 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3720Suppl. Files: 1030PDF: 1017Html: 105 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2123PDF: 916HTML: 5021Cover Letter: 147Figure 2: 138Figure 1: 148Figure 3: 164Figure 4: 146Figure Legend: 163Table 1: 163Table 2: 156Table 3: 156 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3141PDF: 900HTML: 2923 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2722PDF: 814HTML: 6493Untitled: 204Untitled: 167Untitled: 163Untitled: 186 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7186PDF: 2346HTML: 1700Table 1.: 183Table 2.: 199Table 3.: 179Table 4.: 178 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3620PDF: 1597HTML: 11465Figures Haase: 173 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3491PDF: 831HTML: 6693 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
954PDF: 1074Suppl. Files: 550HTML: 71 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1130PDF: 706HTML: 1327Figure 1: 153Figure 2: 150 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1927PDF: 731HTML: 3098 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3755PDF: 1402HTML: 8483 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4182PDF: 1332HTML: 2022 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3448PDF: 1029HTML: 864 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1669PDF: 921HTML: 126 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3370PDF: 1442HTML: 63 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1223PDF: 765HTML: 111 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1723PDF: 777HTML: 10203Figures 1,2,3: 150 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1900PDF: 682HTML: 668Table1: patient's characteristics: 136Table 2: profile of each patient: 161







